Firms
Early-stage venture firm investing in European semiconductors, photonics and advanced materials.
Founded —
Type Venture capital Funds1 Cloudberry VC Fund 1 Ky 2025-12-18 2025-12-18 €30M EUR30m initial close only, not finalclose/AUM; manager CloudberryVCOy3414592-9, fund3567077-6, GP3560529-6. EUR35m maximum and >EUR100m futureambition not closedcapital.
SHOW MORE
Team$1M $100K – $5M Helsinki, Finland $652K $301K – $1M United Kingdom $1M $100K – $5M
SHOW MORE
Co-investingNo co-investors on record yet.
Investments
team@apexlogos.ai · 23 hours ago
Investment-fund research reviewed 2026-10-06. Publicly identified funds, dates, amounts and fundraising status are below. Undisclosed commitments remain unknown; this is not a complete register of private SPVs or parallel entities.
Fund size, status and investment stages
| Evidence | Amount/status | Interpretation |
| --- | --- | --- |
| [Tesi fund announcement](https://tesi.fi/en/news-item/semiconductor-venture-fund-cloudberry/ ), **2025-12-18** | €30m fund launched; anchored by Tesi, with GlobalFoundries, Radiant OptoElectronics and other LPs | Official LP confirmation of the first fund, not manager-wide AUM. |
| [Semiconductor Today](https://www.semiconductor-today.com/news_items/2026/jan/cloudberry-020126.shtml ), **2026-01-02** | €30m **initial close** | Corroborates closed capital rather than a fundraising target; plans up to 20 investments. |
| [Official homepage](https://cloudberry.vc/ ), undated, accessed 2026-10-06 | €30m fund; €400k–€1m initial investments; pre-seed/seed | Current advertised strategy and check size, distinct from total round amounts. |
| [Public Business Tampere presentation](https://businesstampere.com/media/20260420-chip-happens.pdf ), file dated **2026-04-20** | €30m first close completed; €35m maximum | A maximum/hard-cap indication, not evidence that €35m closed. Deck includes a “Confidential” label although publicly hosted; re-confirm before importing hard-cap data. |
| [Tesi case study](https://tesi.fi/en/case/cloudberry/ ), undated, accessed 2026-10-06 | Next-fund ambition **over €100m** | Future target/ambition only; no second-fund close verified. |
The €30m first close is the latest-known verified closed fund size from sources checked. No later final close, €35m close or second-fund close was found. No independently verified total AUM was found. The [official news index](https://cloudberry.vc/news ) dates its launch article **2025-02-01**, conflicting with Tesi's December 2025 public announcement and subsequent January 2026 reporting; treat the index date as a chronology discrepancy rather than establishing a February closing date.
[Official disclosures](https://cloudberry.vc/disclosures.html ), May 2026, explicitly say the fund invests in seed and pre-seed unlisted semiconductor, photonics and advanced-materials businesses. The homepage states mainly Europe. This is the current mandate. Growth-stage capital is a longer-term platform ambition in Semiconductor Today, not evidence of a present general growth-stage mandate. [Silicon Semiconductor's interview](https://siliconsemiconductor.net/article/124152/Cloudberry_VC_launches_Europe%E2%80%99s_first_semiconductor_venture_fund ), **2026-05-07**, reports €300k–€1m checks and approximately 70% capital reserved for follow-ons; its €300k lower bound differs from the homepage's €400k. Preserve the source/date distinction; no transaction below €400k was independently confirmed here.
Funds recorded in Adex after this review:
| Fund | Disclosed amount | Announcement / filing date |
| --- | --- | --- |
| Cloudberry VC Fund 1 Ky | EUR 30000000 | 2025-12-18 | SHOW MORE
team@apexlogos.ai · 23 hours ago
Match research 2026-10-06 / CloudberryVC / sha256:86b9b3fe4b52349770701d43f347aaf5441f73cb69aabf079ebb7833692696d6 / part 2 of 2
Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats.
These are named examples, not an exhaustive portfolio reconstruction. Partner employment at ASML, Heptagon, Bosch, ams Osram or earlier VC employers is not a Cloudberry VC investment. Likewise, companies contributing to a semiconductor report alongside Cloudberry are not automatically portfolio companies. [Siemens' official collaboration announcement](https://news.siemens.com/es-mx/siemens-cre8ventures-cloudberry-vc/ ), **2026-07-16**, and [Racyics collaboration](https://cloudberry.vc/news/racyics-cloudberry-partnership/ ), **2026-08-13**, describe ecosystem partnerships, not equity investments in Siemens or Racyics.
## Neurotech and adjacent evidence
**No verified neurotech investment found in the sources checked.** Searches covered the firm name with neurotech/brain terms, its official news/strategy, Signal and the named portfolio evidence above. This is a bounded finding, not proof that no such investments exist.
**Proteins.1 is adjacent to neurotechnology:** VTT's 2026-04-16 announcement lists neurological research among initial applications, and Cloudberry's investment article mentions neurodegeneration biomarkers. Its evidenced platform detects molecules in samples; it is not a demonstrated brain-computer interface, neural recording device, neuromodulation platform or neural implant. Record neurological diagnostics relevance separately from direct neurotech investment history. Scientific sensitivity, validation and commercial forecasts in the investor article are promotional claims, not independently assessed clinical performance in this research.
## Conflicts, missing information and later Adex review
1. Preserve exact ID `CloudberryVC` and distinct `CloudberryVentures`. Reputable reporting can still misname the investor: Proteins.1's GEN article is a concrete example, resolved here by VTT and the firm's named investment statement.
2. Review adding the legal manager/fund identities, current European pre-seed/seed mandate and €30m initial close, dated December 2025. Do not substitute future >€100m ambitions, €35m maximum, check sizes or portfolio-round amounts for fund size.
3. Review the omitted René Kromhof founding-partner role and duplicate Veera/Lawrence roles; current official team evidence supports the three founders. Do not infer role start dates.
4. Review Proteins.1 and Last Mile Semiconductor as attributable investments; resolve seed/pre-seed terminology for Proteins.1 and seek actual round details for LMS. PROUD merits follow-up with its official company announcement before detailed round import.
5. Reconcile official news-index launch date with LP announcement; reconcile €300k versus €400k advertised minimum tickets. First-close amount is clear, but final-close amount/date, latest AUM, current portfolio count and precise investment amounts are missing.
6. Keep neurotech status as “no verified direct investment found,” with adjacent neurological biomarker evidence recorded separately. The Signal firm profile was readable but thin; it does not verify team history or transactions.
All external URLs above were accessed **2026-10-06**; publication dates are stated where available. This file is research only for a later authorized Adex review. SHOW MORE
team@apexlogos.ai · 23 hours ago
Match research 2026-10-06 / CloudberryVC / sha256:86b9b3fe4b52349770701d43f347aaf5441f73cb69aabf079ebb7833692696d6 / part 1 of 2
Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats.
# Cloudberry VC — Match firm research
- Exact Adex ID: `CloudberryVC`
- Canonical Adex URL: https://adex.page/firms/CloudberryVC
- Research date and web access date: **2026-10-06**
- Status: complete research for later review; no Adex/database changes made.
## Identity and summary
Cloudberry VC is a Helsinki/London semiconductor specialist backing European pre-seed and seed businesses in semiconductors, photonics and advanced materials. Its latest-known publicly evidenced first fund has a **€30 million initial close**. Verified named investments include Proteins.1 and Last Mile Semiconductor; official indexed news also identifies PROUD, with less complete transaction evidence. No verified direct neurotech investment was found; Proteins.1 has neurological biomarker applications but is an adjacent diagnostics platform. Sources and limits follow.
The [official disclosures](https://cloudberry.vc/disclosures.html ), updated May 2026, identify manager **Cloudberry VC Oy**, Finnish business ID 3414592-9, fund **Cloudberry VC Fund 1 Ky**, business ID 3567077-6, and GP **Cloudberry VC Fund 1 GP Oy**, business ID 3560529-6. The manager describes itself as a registered AIFM supervised by FIN-FSA. [Tesi's official case study](https://tesi.fi/en/case/cloudberry/ ) identifies founding partners René Kromhof, Veera Pietikäinen and Lawrence Lundy-Bryan, and venture partners Lukas Steinmann and Tuomas Hollman (undated, accessed 2026-10-06).
**Keep separate from `CloudberryVentures`.** The latter uses cloudberry.ventures and is associated with Mahir Sahin; its [official portfolio](https://www.cloudberry.ventures/portfolio ) includes companies such as Quantum Dice, Xavveo and Peak Quantum. Those are not attributable to Cloudberry VC simply because an article uses “Cloudberry.” Cloudberry Clean Energy is also unrelated to this record.
## Starting evidence: Adex and NFX Signal
The exact-ID saved snapshot, `data/research/_sources/CloudberryVC.adex.json`, was retrieved through read-only Adex MCP Search on 2026-10-06 at 19:29:43 UTC. It describes an early-stage European semiconductor/photonics/advanced-materials investor; lists Lawrence Lundy-Bryan and Veera Pietikäinen; contains no previous investments, fund size or check-size data; and expressly distinguishes Cloudberry VC from Cloudberry Ventures. Duplicate partner-role entries appear with differently formatted titles. These are baseline database claims, not independent verification.
[NFX Signal firm profile](https://signal.nfx.com/firms/cloudberry-vc ) was directly read successfully after an initial tool error. Its accessible text identifies “Cloudberry VC” and locations United Kingdom/Helsinki, Finland; the team section provides no usable names, stages, amounts or portfolio details. The [Signal DeepTech Pre-Seed investor list](https://signal.nfx.com/investor-lists/top-deeptech-pre-seed-investors ) was directly read and includes Cloudberry VC linking to this exact profile. Both are undated and accessed 2026-10-06. List inclusion supports a research lead, not verified investments or an exclusive mandate; official disclosures substantiate the stage and sector focus.
## Fund size, status and investment stages
| Evidence | Amount/status | Interpretation |
| --- | --- | --- |
| [Tesi fund announcement](https://tesi.fi/en/news-item/semiconductor-venture-fund-cloudberry/ ), **2025-12-18** | €30m fund launched; anchored by Tesi, with GlobalFoundries, Radiant OptoElectronics and other LPs | Official LP confirmation of the first fund, not manager-wide AUM. |
| [Semiconductor Today](https://www.semiconductor-today.com/news_items/2026/jan/cloudberry-020126.shtml ), **2026-01-02** | €30m **initial close** | Corroborates closed capital rather than a fundraising target; plans up to 20 investments. |
| [Official homepage](https://cloudberry.vc/ ), undated, accessed 2026-10-06 | €30m fund; €400k–€1m initial investments; pre-seed/seed | Current advertised strategy and check size, distinct from total round amounts. |
| [Public Business Tampere presentation](https://businesstampere.com/media/20260420-chip-happens.pdf ), file dated **2026-04-20** | €30m first close completed; €35m maximum | A maximum/hard-cap indication, not evidence that €35m closed. Deck includes a “Confidential” label although publicly hosted; re-confirm before importing hard-cap data. |
| [Tesi case study](https://tesi.fi/en/case/cloudberry/ ), undated, accessed 2026-10-06 | Next-fund ambition **over €100m** | Future target/ambition only; no second-fund close verified. |
The €30m first close is the latest-known verified closed fund size from sources checked. No later final close, €35m close or second-fund close was found. No independently verified total AUM was found. The [official news index](https://cloudberry.vc/news ) dates its launch article **2025-02-01**, conflicting with Tesi's December 2025 public announcement and subsequent January 2026 reporting; treat the index date as a chronology discrepancy rather than establishing a February closing date.
[Official disclosures](https://cloudberry.vc/disclosures.html ), May 2026, explicitly say the fund invests in seed and pre-seed unlisted semiconductor, photonics and advanced-materials businesses. The homepage states mainly Europe. This is the current mandate. Growth-stage capital is a longer-term platform ambition in Semiconductor Today, not evidence of a present general growth-stage mandate. [Silicon Semiconductor's interview](https://siliconsemiconductor.net/article/124152/Cloudberry_VC_launches_Europe%E2%80%99s_first_semiconductor_venture_fund ), **2026-05-07**, reports €300k–€1m checks and approximately 70% capital reserved for follow-ons; its €300k lower bound differs from the homepage's €400k. Preserve the source/date distinction; no transaction below €400k was independently confirmed here.
## Named previous deep-tech investments
| Company | Technology and firm attribution | Round/date and evidence limits |
| --- | --- | --- |
| **Proteins.1**, Finland | Semiconductor sensing, magnetic beads and microfluidics for enzyme-free single-molecule protein detection: a defensible deep-tech diagnostics investment. Cloudberry VC's [investment thesis](https://cloudberry.vc/news/why-we-invested-in-proteins-1/ ), **2026-04-16**, explicitly describes its backing and co-investment with Lifeline Ventures. VTT, the technology-originating institution, independently names **Cloudberry VC**. | [VTT announcement](https://www.vttresearch.com/fi/uutiset-ja-tarinat/sairauksien-varhainen-havainnointi-proteins1-hyodyntaa-vttlla-kehitettya ), **2026-04-16**, says €4.7m seed financing led by Lifeline Ventures and Cloudberry VC, plus VTT/Business Finland support. [GEN reporting](https://www.genengnews.com/topics/omics/proteins-1-launches-to-develop-single-molecule-protein-amplification-tech-for-diagnostics/ ), **2026-04-16**, labels it **pre-seed**, but inconsistently calls the investor Cloudberry Ventures while quoting René Kromhof of Cloudberry VC. Use VTT and Cloudberry VC's own announcement for identity. €4.7m is total round financing, not Cloudberry's check. Exact legal round label and equity/support composition need confirmation. |
| **Last Mile Semiconductor**, Dresden, Germany | Mixed-signal silicon integrating a DECT NR+ radio, processing, AI engine and security; semiconductor hardware, not ordinary SaaS. [Cloudberry VC's own investment article](https://cloudberry.vc/news/why-we-invested-in-last-mile-semiconductor/ ), **2026-07-13**, explicitly states backing. | Investment confirmed by publication date; actual closing date, round label, total financing and individual check not disclosed in the checked article. Its August 2025 first manufacturing run is a product milestone, not the investment date. GlobalFoundries' LP/manufacturing relationship is strategic support, not separate proof of a round. |
| **PROUD**, Switzerland | Diamond growth directly on chips for thermal management. The [official news index](https://cloudberry.vc/news ), accessed 2026-10-06, lists **“Why We Invested in PROUD,” 2026-06-10**, describing diamond growth at 400°C. This establishes named firm backing at the level of the firm's indexed announcement. | Full linked article could not be retrieved in this run. Round, amount and closing date remain unverified. Tesi's undated case study discusses a Swiss diamond-cooling investment nearing completion without naming it; this is a corroborating technology lead, not independent named transaction proof. Keep this row at lower confidence than Proteins.1/LMS until investee confirmation. | SHOW MORE
team@apexlogos.ai · 26 days ago
MATCH